GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement
GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., has announced two key executive appointments. Aaron Crittenden has been named President of Rx Marketplace, while Scott Pope, PharmD, becomes Chief Pharmacy Officer and Head of Clinical Engagement.
Crittenden, who joined GoodRx in 2020, will manage the Rx Marketplace offering and work with retail pharmacy, PBM, employer, and manufacturer partners. As former Head of Manufacturer Solutions and Chief Revenue Officer, he helped grow revenue to over $100M. Pope brings nearly 30 years of healthcare experience and will oversee relationships with healthcare professionals, including marketing and product development.
GoodRx serves nearly 30 million consumers and over one million healthcare professionals annually. Since 2011, the platform has helped Americans save over $85 billion on medication costs by connecting consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies.
GoodRx (Nasdaq: GDRX), la principale piattaforma di risparmio sui farmaci negli Stati Uniti, ha annunciato due importanti nomine esecutive. Aaron Crittenden è stato nominato Presidente di Rx Marketplace, mentre Scott Pope, PharmD, diventa Chief Pharmacy Officer e Responsabile dell'Engagement Clinico.
Crittenden, che è entrato in GoodRx nel 2020, gestirà l'offerta di Rx Marketplace e collaborerà con farmacie al dettaglio, PBM, datori di lavoro e partner produttori. In qualità di ex Responsabile delle Soluzioni per i Produttori e Chief Revenue Officer, ha contribuito a far crescere le entrate oltre i 100 milioni di dollari. Pope porta con sé quasi 30 anni di esperienza nel settore sanitario e supervisionerà le relazioni con i professionisti della salute, inclusi marketing e sviluppo del prodotto.
GoodRx serve quasi 30 milioni di consumatori e oltre un milione di professionisti della salute ogni anno. Dal 2011, la piattaforma ha aiutato gli americani a risparmiare oltre 85 miliardi di dollari sui costi dei farmaci, connettendo consumatori, professionisti della salute, pagatori, PBM, produttori farmaceutici e farmacie al dettaglio.
GoodRx (Nasdaq: GDRX), la principal plataforma de ahorro en medicamentos en EE. UU., ha anunciado dos nombramientos ejecutivos clave. Aaron Crittenden ha sido nombrado Presidente de Rx Marketplace, mientras que Scott Pope, PharmD, se convierte en Director de Farmacia y Jefe de Compromiso Clínico.
Crittenden, quien se unió a GoodRx en 2020, gestionará la oferta de Rx Marketplace y trabajará con farmacias minoristas, PBM, empleadores y socios fabricantes. Como ex Jefe de Soluciones para Fabricantes y Director de Ingresos, ayudó a aumentar los ingresos a más de 100 millones de dólares. Pope aporta casi 30 años de experiencia en el sector salud y supervisará las relaciones con profesionales de la salud, incluyendo marketing y desarrollo de productos.
GoodRx atiende a casi 30 millones de consumidores y más de un millón de profesionales de la salud anualmente. Desde 2011, la plataforma ha ayudado a los estadounidenses a ahorrar más de 85 mil millones de dólares en costos de medicamentos al conectar a consumidores, profesionales de la salud, pagadores, PBM, fabricantes farmacéuticos y farmacias minoristas.
GoodRx (Nasdaq: GDRX), 미국의 주요 약품 절약 플랫폼, 두 명의 주요 임원 임명을 발표했습니다. Aaron Crittenden가 Rx Marketplace의 사장으로 임명되었고, Scott Pope, PharmD는 최고 약국 책임자 및 임상 참여 책임자가 되었습니다.
Crittenden은 2020년에 GoodRx에 합류하여 Rx Marketplace의 제공을 관리하고 소매 약국, PBM, 고용주 및 제조업체 파트너와 협력할 것입니다. 그는 이전에 제조업체 솔루션 책임자 및 수익 책임자로 재직하며 수익을 1억 달러 이상으로 성장시키는 데 기여했습니다. Pope는 거의 30년의 의료 경험을 가지고 있으며, 마케팅 및 제품 개발을 포함한 의료 전문가와의 관계를 감독할 것입니다.
GoodRx는 매년 거의 3천만 소비자와 100만 명 이상의 의료 전문가에게 서비스를 제공합니다. 2011년 이후, 이 플랫폼은 소비자, 의료 전문가, 지불자, PBM, 제약 제조업체 및 소매 약국을 연결하여 미국인들이 약품 비용에서 850억 달러 이상을 절약하도록 도왔습니다.
GoodRx (Nasdaq: GDRX), la principale plateforme d'économies sur les médicaments aux États-Unis, a annoncé deux nominations exécutives clés. Aaron Crittenden a été nommé Président de Rx Marketplace, tandis que Scott Pope, PharmD, devient Directeur de la Pharmacie et Responsable de l'Engagement Clinique.
Crittenden, qui a rejoint GoodRx en 2020, gérera l'offre de Rx Marketplace et travaillera avec des pharmacies de détail, des PBM, des employeurs et des partenaires fabricants. En tant qu'ancien Responsable des Solutions Fabricants et Directeur des Revenus, il a contribué à faire croître le chiffre d'affaires à plus de 100 millions de dollars. Pope apporte près de 30 ans d'expérience dans le secteur de la santé et supervisera les relations avec les professionnels de la santé, y compris le marketing et le développement de produits.
GoodRx sert près de 30 millions de consommateurs et plus d'un million de professionnels de la santé chaque année. Depuis 2011, la plateforme a aidé les Américains à économiser plus de 85 milliards de dollars sur les coûts des médicaments en connectant les consommateurs, les professionnels de la santé, les payeurs, les PBM, les fabricants pharmaceutiques et les pharmacies de détail.
GoodRx (Nasdaq: GDRX), die führende Plattform für Medikamenteneinsparungen in den USA, hat zwei wichtige Führungskräfte ernannt. Aaron Crittenden wurde zum Präsidenten des Rx Marketplace ernannt, während Scott Pope, PharmD, zum Chief Pharmacy Officer und Leiter des klinischen Engagements wird.
Crittenden, der 2020 zu GoodRx kam, wird das Angebot des Rx Marketplace verwalten und mit Einzelhandelsapotheken, PBM, Arbeitgebern und Herstellern zusammenarbeiten. Als ehemaliger Leiter der Herstellerlösungen und Chief Revenue Officer half er, den Umsatz auf über 100 Millionen Dollar zu steigern. Pope bringt fast 30 Jahre Erfahrung im Gesundheitswesen mit und wird die Beziehungen zu Gesundheitsfachkräften, einschließlich Marketing und Produktentwicklung, überwachen.
GoodRx bedient jährlich fast 30 Millionen Verbraucher und über eine Million Gesundheitsfachkräfte. Seit 2011 hat die Plattform den Amerikanern geholfen, über 85 Milliarden Dollar bei den Medikamentenkosten zu sparen, indem sie Verbraucher, Gesundheitsfachkräfte, Zahler, PBM, Pharmahersteller und Einzelhandelsapotheken miteinander verbindet.
- Strategic executive appointments strengthen leadership team with experienced healthcare professionals
- Proven track record of revenue growth to $100M+ under Crittenden's leadership
- Large user base of 30 million consumers and 1 million healthcare professionals annually
- Demonstrated success in medication cost savings, with $85 billion saved since 2011
- Forward-looking statements indicate risks in achieving broad market education
- Business model relies on number of industry participants
- Potential challenges in changing consumer purchasing habits
Accomplished healthcare executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx
Aaron will be responsible for the management and financial performance of GoodRx’s Rx Marketplace offering, working with key retail pharmacy, pharmacy benefit manager (PBM), employer, and manufacturer partners. He will also play a critical role in shaping GoodRx’s long-term growth strategy and serve as a strategic advisor to the CEO and President, helping to guide the company’s broader vision and business priorities.
Since joining GoodRx in 2020, Aaron has played a pivotal role in building and scaling the business across multiple leadership positions. As Head of Manufacturer Solutions and then Chief Revenue Officer, Aaron helped launch the company’s Pharma Manufacturer Solutions offering and played a key role in growing revenue to
Scott will be responsible for all aspects of GoodRx’s relationships with physicians, pharmacists, nurses, and all healthcare professionals, including marketing and product development. This includes pharmacy strategy, clinical engagement, and industry partnerships.
By joining GoodRx, Scott will continue his nearly 30 years of successful service in the
“Our path forward is laser-focused on improving the prescription experience for all stakeholders, from the retail pharmacies looking to innovate and drive profitability to the healthcare professionals seeking affordable medication solutions for their patients so they can adhere to their treatment plans,” said Wendy Barnes, Chief Executive Officer and President of GoodRx. “I’m confident Aaron and Scott are the right leaders to help us deliver against these key business priorities and accelerate our efforts to fill gaps in insurance coverage and reduce friction across the healthcare system.”
About GoodRx
GoodRx is the leading platform for medication savings in the
GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.
GoodRx Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, the statements regarding anticipated future performance of the Company and expected benefits to the Company related to these executive appointments. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250317163984/en/
Media Contact
Lauren Casparis
press@goodrx.com
Source: GoodRx
FAQ
What are Aaron Crittenden's responsibilities as the new President of Rx Marketplace at GoodRx (GDRX)?
How much revenue growth did Aaron Crittenden help achieve at GoodRx (GDRX)?
What is Scott Pope's role as Chief Pharmacy Officer at GoodRx (GDRX)?
How many consumers and healthcare professionals use GoodRx (GDRX) annually?
How much have Americans saved on medications through GoodRx (GDRX) since 2011?
